These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 462584)

  • 21. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D
    Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy for known residual disease after resection of gastric and colorectal cancer.
    Giles GR; Lawton JO
    Recent Results Cancer Res; 1978; 68():212-6. PubMed ID: 752858
    [No Abstract]   [Full Text] [Related]  

  • 24. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy.
    Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK
    Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
    Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
    J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyl-CCNU and ftorafur in treatment of rectosigmoidal tumors and ftorafur capsules in treatment of colorectal tumors.
    Mechl Z; Malír
    Recent Results Cancer Res; 1981; 79():59-64. PubMed ID: 6795699
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
    White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
    Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorouracil, methyl-CCNU and vincristine in cancer of the colon.
    Falkson G; Falkson HC
    Cancer; 1976 Oct; 38(4):1468-70. PubMed ID: 791472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
    Kemeny N; Yagoda A; Braun D; Golbey R
    Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer.
    Aroney RS; Dalley DN; Chan WK; Bell DR; Levi JA
    Med Pediatr Oncol; 1981; 9(2):181-6. PubMed ID: 7231364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
    Joss RA; Goldberg RS; Yates JW
    Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
    Belt RJ; Stephens R
    Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
    Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP
    Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
    Rossi A; Riva A; Bonadonna G
    Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.
    Sutton JE; Roos IA; Hillcoat BL
    Cancer Res; 1982 Dec; 42(12):5172-5. PubMed ID: 7139620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic colorectal cancer. Combination chemotherapy in patients previously treated with 5-fluorouracil.
    Moayeri H; DiBenedetto J; Mittelman A
    N Y State J Med; 1980 Jul; 80(8):1220-4. PubMed ID: 6931307
    [No Abstract]   [Full Text] [Related]  

  • 39. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
    Trux F
    Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.